Literature DB >> 7789061

Anticardiolipin antibodies in the polymyalgia rheumatica-temporal arteritis syndromes.

R M McLean, T P Greco.   

Abstract

A series of seven patients with the polymyalgia rheumatica-temporal arteritis (PMR-TA) complex is presented, each of whom during the clinical course demonstrated the presence of anticardiolipin antibodies (ACLs). Presenting symptoms consisted of proximal myalgias and stiffness characteristic of PMR in five patients and of visual symptoms and headache suspicious for TA in two patients. Two of the five PMR patients later developed jaw claudication characteristic of TA. Six of the seven cases demonstrated clinical evidence of a vasculopathic process such as a cerebrovascular infarct or a vasculitic syndrome. Previous studies have suggested an association between ACLs and PMR-TA, and this series of patients appears to provide more supporting evidence. Even patients who only manifested PMR symptoms without suggestion of accompanying TA developed vascular complications. An increasing range of symptoms have been recognized in association with ACLs, and the vasculitic syndromes of PMR-TA should be included as a possible association. While this series together with previous studies may suggest that the presence of ACLs in patients with PMR-TA symptoms may serve as a marker for the development of vascular complications, larger longitudinal studies will be necessary in the future.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7789061     DOI: 10.1007/bf02214942

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  19 in total

Review 1.  Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance.

Authors:  P E Love; S A Santoro
Journal:  Ann Intern Med       Date:  1990-05-01       Impact factor: 25.391

Review 2.  Temporal arteritis.

Authors:  B W Goodman
Journal:  Am J Med       Date:  1979-11       Impact factor: 4.965

Review 3.  Anticardiolipin antibodies--clinical associations.

Authors:  R A Asherson; E N Harris
Journal:  Postgrad Med J       Date:  1986-12       Impact factor: 2.401

4.  Anticardiolipin and antineutrophil antibodies in giant cell arteritis.

Authors:  N J McHugh; I E James; G T Plant
Journal:  J Rheumatol       Date:  1990-07       Impact factor: 4.666

5.  Anticardiolipin antibodies in patients with rheumatic diseases.

Authors:  J G Fort; F S Cowchock; J L Abruzzo; J B Smith
Journal:  Arthritis Rheum       Date:  1987-07

6.  Temporal arteritis: a 25-year epidemiologic, clinical, and pathologic study.

Authors:  K A Huston; G G Hunder; J T Lie; R H Kennedy; L R Elveback
Journal:  Ann Intern Med       Date:  1978-02       Impact factor: 25.391

7.  Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986.

Authors:  E N Harris; A E Gharavi; S P Patel; G R Hughes
Journal:  Clin Exp Immunol       Date:  1987-04       Impact factor: 4.330

8.  Polymyalgia rheumatica and temporal arteritis: a retrospective analysis of prognostic features and different corticosteroid regimens (11 year survey of 210 patients).

Authors:  G Delecoeuillerie; P Joly; A Cohen de Lara; J B Paolaggi
Journal:  Ann Rheum Dis       Date:  1988-09       Impact factor: 19.103

Review 9.  Which patients with antiphospholipid antibody should be treated and how?

Authors:  M D Lockshin
Journal:  Rheum Dis Clin North Am       Date:  1993-02       Impact factor: 2.670

10.  Polymyalgia rheumatica: a 10-year epidemiologic and clinical study.

Authors:  T Y Chuang; G G Hunder; D M Ilstrup; L T Kurland
Journal:  Ann Intern Med       Date:  1982-11       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.